Harvard Apparatus Regenerative Technology Inc. (HRGN)
OTCMKTS · Delayed Price · Currency is USD
1.660
+0.110 (7.10%)
Aug 21, 2025, 9:30 AM EDT
HRGN Market Cap
HRGN has a market cap or net worth of $28.41 million as of August 22, 2025. Its market cap has decreased by -54.73% in one year.
Market Cap
28.41M
Enterprise Value
27.88M
Revenue
679.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.66
Market Cap Chart
Since October 21, 2013, HRGN's market cap has decreased from 48.00M to 28.41M, a decrease of -40.80%. That is a compound annual growth rate of -4.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 28.41M | -40.10% |
| Dec 30, 2024 | 47.44M | -31.84% |
| Dec 29, 2023 | 69.60M | 3.94% |
| Dec 30, 2022 | 66.96M | 170.54% |
| Dec 31, 2021 | 24.75M | 110.90% |
| Dec 31, 2020 | 11.74M | -25.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Glass House Brands | 632.06M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 368.43M |